Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease
Jingnan Chen, Xitong Wang, Tian Xia, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 111927-111927
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

A poloxamer/hyaluronic acid/chitosan-based thermosensitive hydrogel that releases dihydromyricetin to promote wound healing
Yingchun Zhao, Xinglong Liu, Xiaojuan Peng, et al.
International Journal of Biological Macromolecules (2022) Vol. 216, pp. 475-486
Closed Access | Times Cited: 40
Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosis
Zheming Xu, Minjing Zhang, Wenwen Wang, et al.
Toxicology and Applied Pharmacology (2023) Vol. 473, pp. 116595-116595
Closed Access | Times Cited: 29
Targeted intervention of natural medicinal active ingredients and traditional Chinese medicine on epigenetic modification: Possible strategies for prevention and treatment of atherosclerosis
Wei Wang, Han Li, Ying Shi, et al.
Phytomedicine (2023) Vol. 122, pp. 155139-155139
Closed Access | Times Cited: 28
Polyvinylpyrrolidone/chitosan-loaded dihydromyricetin-based nanofiber membrane promotes diabetic wound healing by anti-inflammatory and regulating autophagy-associated protein expression
Xinglong Liu, Shijie Wang, Chuanbo Ding, et al.
International Journal of Biological Macromolecules (2024) Vol. 259, pp. 129160-129160
Closed Access | Times Cited: 9
Hepatoprotective potential of four fruit extracts rich in different structural flavonoids against alcohol-induced liver injury via gut microbiota-liver axis
Yunyi Chen, Hanbing Ma, Jiaojiao Liang, et al.
Food Chemistry (2024) Vol. 460, pp. 140460-140460
Closed Access | Times Cited: 9
Recent update on application of dihydromyricetin in metabolic related diseases
Yirong Wang, Junmin Wang, Hongjiao Xiang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112771-112771
Open Access | Times Cited: 31
An integrated network pharmacology approach reveals that Ampelopsis grossedentata improves alcoholic liver disease via TLR4/NF-κB/MLKL pathway
Ping Qiu, Ai Mi, Chunlan Hong, et al.
Phytomedicine (2024) Vol. 132, pp. 155658-155658
Closed Access | Times Cited: 7
Dihydromyricetin alleviates methotrexate-induced hepatotoxicity via suppressing the ‎TLR4/NF-κB pathway and NLRP3 inflammasome/caspase 1 axis
Asmaa I. Matouk, Eman M. Awad, Nashwa Fathy Gamal El‐Tahawy, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113752-113752
Open Access | Times Cited: 23
A double-layered gastric floating tablet for zero-order controlled release of dihydromyricetin: Design, development, and in vitro/in vivo evaluation
Ruirui Zhang, Houyin Shi, Sifang Li, et al.
International Journal of Pharmaceutics (2023) Vol. 638, pp. 122929-122929
Closed Access | Times Cited: 13
Flavonoids-based nanomedicines for the treatment of liver fibrosis: A recent progress
Karthik Shree Harini, Devaraj Ezhilarasan
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105467-105467
Closed Access | Times Cited: 5
Chemical profiling and quality evaluation of Liuweizhiji Gegen‐Sangshen oral liquid by UPLC‐Q‐TOF‐MS and HPLC‐diode array detector fingerprinting
Shulin Wei, Yu Jiang, Mingxing Li, et al.
Phytochemical Analysis (2024) Vol. 35, Iss. 4, pp. 860-872
Closed Access | Times Cited: 5
Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges
Ruirui Zhang, Hao Zhang, Houyin Shi, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 3052-3070
Open Access | Times Cited: 22
Dihydromyricetin Modulates Nrf2 and NF-κB Crosstalk to Alleviate Methotrexate-Induced Lung Toxicity
Asmaa I. Matouk, Eman M. Awad, Nashwa Fathy Gamal El‐Tahawy, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 481-481
Open Access | Times Cited: 11
Preventive and therapeutic effects of natural products and herbal extracts on nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yiming Cao, Xiaoxue Fang, Mingyang Sun, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 9, pp. 3867-3897
Open Access | Times Cited: 11
Fingerprint profiling for quality evaluation and the related biological activity analysis of polysaccharides from Liuweizhiji Gegen-Sangshen beverage
Shulin Wei, Mingxing Li, Long Zhao, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 4
Dihydromyricetin as a Dietary Supplement Enhances Hypoglycemic Efficacy: Synergistic Modulation of the Gut-Liver with Sangzhi Alkaloids
Yuwen Guan, Qiuyue Lv, Xinyu Wang, et al.
Food Bioscience (2025), pp. 106197-106197
Closed Access
Exploring the Nutraceutical Potential of a Food–Medicine Compound for Metabolic-Associated Fatty Liver Disease via Lipidomics and Network Pharmacology
Yuru Deng, Jie Cui, Yuxuan Jiang, et al.
Foods (2025) Vol. 14, Iss. 7, pp. 1257-1257
Open Access
Research progress of dihydromyricetin in the treatment of diabetes mellitus
Ziyuan Wang, Zhuoran Cao, Zhiying Yue, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
LanGui tea, an herbal medicine formula, protects against binge alcohol-induced acute liver injury by activating AMPK-NLRP3 signaling
Ming Gu, Yujun Chen, Yaru Feng, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Patents on the move: The therapeutic future of liquid crystals in cancer
Silvia Vitória Silva Cézar, Alcimary Bispo Santos, Anamaria Mendonça Santos, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 97, pp. 105822-105822
Closed Access | Times Cited: 3
Modulation of Keap-1/Nrf2/HO-1 and NF-ĸB/caspase-3 signaling pathways by Dihydromyricetin Ameliorates Sodium Valproate-Induced Liver Injury
Doaa Emad, Asmaa M. A. Bayoumi, Sahar M. Gebril, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 758, pp. 110084-110084
Closed Access | Times Cited: 3
Vine tea kombucha ameliorates non-alcoholic fatty liver disease in high-fat diet fed mice via antioxidation, anti-inflammation and regulation of gut microbiota
Jin Cheng, Siyu Huang, Ruo-Gu Xiong, et al.
Food Bioscience (2024) Vol. 62, pp. 105400-105400
Closed Access | Times Cited: 3
The pharmacological role of Ginsenoside Rg3 in liver diseases: A review on molecular mechanisms
Wenhong Wang, Ke Li, Weihua Xiao
Journal of Ginseng Research (2023) Vol. 48, Iss. 2, pp. 129-139
Open Access | Times Cited: 8
Dihydromyricetin alleviates inflammatory bowel disease associated intestinal fibrosis by inducing autophagy through the PI3K/AKT/mTOR signaling pathway
Xiaochun Wang, Xiaoli Li, XueNi Ma, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 6, pp. 4183-4194
Open Access | Times Cited: 7
Dietary Dihydromyricetin Zinc Chelate Supplementation Improves the Intestinal Health of Magang Geese
Renkai Wang, Yanli Ren, Hafiz Umer Javad, et al.
Biological Trace Element Research (2024) Vol. 202, Iss. 11, pp. 5219-5234
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top